Ann Oncol -- Table of Contents (March 2003, 14 [3])

Oxford Journals

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 14, No. 3 March 2003   [Index by Author]      Other Issues:

       Editorial

       Reviews

       Original articles

              Head and neck cancer

              Gastrointestinal tumors

              Breast cancer

              Gynecologic tumors

              Lung cancer

              Hematologic malignancies

              Phase I

              Epidemiology

       Letters to the Editor

       Book reviews

Find articles in this issue containing these words:
[Search ALL Issues]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Editorial:

G. Pentheroudakis and N. Pavlidis: Immunomodulation in colorectal cancer: disappointment or promise?
Ann Oncol 14: 349-351; doi:10.1093/annonc/mdg122
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

N. Gray and L. T. Kozlowski: More on the regulation of tobacco smoke: how we got here and where next
Ann Oncol 14: 353-357; doi:10.1093/annonc/mdg103
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

R. F. Kefford: Adjuvant therapy of cutaneous melanoma: the interferon debate
Ann Oncol 14: 358-365; doi:10.1093/annonc/mdg120
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Head and neck cancer:

L. Licitra, L. D. Locati, R. Cavina, I. Garassino, F. Mattavelli, N. Pizzi, P. Quattrone, P. Valagussa, L. Gianni, G. Bonadonna, C. L. Solero, and G. Cantu: Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer
Ann Oncol 14: 367-372; doi:10.1093/annonc/mdg113
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

X. Pivot, A. Awada, D. Gedouin, J. Kerger, F. Rolland, D. Cupissol, F. Caponigro, G. Comella, J. J. Lopez-Pousa, E. Guardiola, B. Giroux, B. Gérard, and M. Schneider: Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer
Ann Oncol 14: 373-377; doi:10.1093/annonc/mdg114
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gastrointestinal tumors:

C. Gennatas, C. Dardoufas, D. Mouratidou, N. Tsavaris, A. Pouli, G. Androulakis, M. Philippakis, D. Voros, T. Batalis, S. Besbeas, G. Hatzistylianos, J. Katsos, V. Komporozos, N. Legakis, H. Mallas, G. Peros, A. Photopoulos, C. Pisiotis, G. Polymeneas, G. Retalis, L. Samanidis, V. Smyrniotis, A. Stamatiadis, J. Vasiliou, H. Andreadis, and J. Papadimitriou: Surgical adjuvant therapy of rectal carcinoma: a controlled evaluation of leucovorin, 5-fluorouracil and radiation therapy with or without interferon- ${alpha}$ 2b
Ann Oncol 14: 378-382; doi:10.1093/annonc/mdg105
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

D. Y. Kim, J. H. Kim, S.-H. Lee, T. Y. Kim, D. S. Heo, Y.-J. Bang, and N. K. Kim: Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer
Ann Oncol 14: 383-387; doi:10.1093/annonc/mdg106
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. P. Stathopoulos, S. K. Rigatos, M. A. Dimopoulos, T. Giannakakis, G. Foutzilas, C. Kouroussis, D. Janninis, G. Aravantinos, N. Androulakis, S. Agelaki, J. G. Stathopoulos, and V. Georgoulias: Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer
Ann Oncol 14: 388-394; doi:10.1093/annonc/mdg109
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

H. T. Arkenau, A. Bermann, K. Rettig, G. Strohmeyer, and R. Porschen: 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial
Ann Oncol 14: 395-399; doi:10.1093/annonc/mdg100
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. C. Earle, E. Grunfeld, D. Coyle, M. C. Cripps, and H. S. Stern: Cancer physicians’ attitudes toward colorectal cancer follow-up
Ann Oncol 14: 400-405; doi:10.1093/annonc/mdg101
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Breast cancer:

H. Bonnefoi, S. Diebold-Berger, P. Therasse, A. Hamilton, M. van de Vijver, G. MacGrogan, L. Shepherd, N. Amaral, C. Duval, R. Drijkoningen, D. Larsimont, and M. Piccart: Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?
Ann Oncol 14: 406-413; doi:10.1093/annonc/mdg108
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Mustacchi, R. Ceccherini, S. Milani, A. Pluchinotta, A. De Matteis, L. Maiorino, A. Farris, A. Scanni, and F. Sasso: Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial
Ann Oncol 14: 414-420; doi:10.1093/annonc/mdg117
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Kerr, J. Engel, A. Schlesinger-Raab, H. Sauer, and D. Hölzel: Communication, quality of life and age: results of a 5-year prospective study in breast cancer patients
Ann Oncol 14: 421-427; doi:10.1093/annonc/mdg098
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Anelli, R. R. Brentani, A. P. Gadelha, A. Amorim de Albuquerque, and F. Soares: Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer
Ann Oncol 14: 428-432; doi:10.1093/annonc/mdg104
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

R. Paridaens, F. Van Aelst, V. Georgoulias, H. Samonnig, V. Cocquyt, C. Zielinski, H. Hausmaninger, P. Willemse, Y. Boudraa, J. Wildiers, C. Ramazeilles, and N. Azli: A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer
Ann Oncol 14: 433-440; doi:10.1093/annonc/mdg111
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gynecologic tumors:

M. S. Aapro, F. H. van Wijk, G. Bolis, B. Chevallier, M. E. L. van der Burg, A. Poveda, C. F. de Oliveira, S. Tumolo, V. Scotto di Palumbo, M. Piccart, M. Franchi, F. Zanaboni, A. J. Lacave, R. Fontanelli, G. Favalli, P. Zola, J. P. Guastalla, R. Rosso, C. Marth, M. Nooij, M. Presti, C. Scarabelli, T. A. W. Splinter, E. Ploch, L. V. A. Beex, W. ten Bokkel Huinink, M. Forni, M. Melpignano, P. Blake, P. Kerbrat, C. Mendiola, A. Cervantes, A. Goupil, P. G. Harper, C. Madronal, M. Namer, G. Scarfone, J. E. G. M. Stoot, I. Teodorovic, C. Coens, I. Vergote, and J. B. Vermorken: Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
Ann Oncol 14: 441-448; doi:10.1093/annonc/mdg112
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Lung cancer:

M. J. Millward, M. J. Boyer, M. Lehnert, S. Clarke, D. Rischin, B.-C. Goh, J. Wong, E. McNeil, and J. F. Bishop: Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients
Ann Oncol 14: 449-454; doi:10.1093/annonc/mdg118
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

E. F. Smit, K. Mattson, J. von Pawel, C. Manegold, S. Clarke, and P. E. Postmus: ALIMTA^® (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study
Ann Oncol 14: 455-460; doi:10.1093/annonc/mdg099
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Gonzalez, T. Crombet, F. Torres, M. Catala, L. Alfonso, M. Osorio, E. Neninger, B. Garcia, A. Mulet, R. Perez, and R. Lage: Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy
Ann Oncol 14: 461-466; doi:10.1093/annonc/mdg102
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

M. J. Terol, M. Tormo, J. A. Martinez-Climent, I. Marugan, I. Benet, A. Ferrandez, A. Teruel, R. Ferrer, and J. García-Conde: Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome
Ann Oncol 14: 467-474; doi:10.1093/annonc/mdg057
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

D. Damiani, R. Stocchi, P. Masolini, A. Michelutti, A. Geromin, A. Sperotto, C. Skert, M. Michieli, M. Baccarani, and R. Fanin: CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection
Ann Oncol 14: 475-480; doi:10.1093/annonc/mdg107
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I:

M. Ychou, T. Conroy, J. F. Seitz, S. Gourgou, A. Hua, D. Mery-Mignard, and A. Kramar: An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors
Ann Oncol 14: 481-489; doi:10.1093/annonc/mdg119
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Epidemiology:

F. Levi, F. Lucchini, E. Negri, P. Boyle, and C. La Vecchia: Mortality from major cancer sites in the European Union, 1955–1998
Ann Oncol 14: 490-495; doi:10.1093/annonc/mdg110
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

C. Garufi, A. Cristaudo, B. Vanni, E. Bria, A. M. Aschelter, B. Santucci, and E. Terzoli: Skin testing and hypersensitivity reactions to oxaliplatin
Ann Oncol 14: 497-498; doi:10.1093/annonc/mdg092
[Extract] [FREE Full Text] [PDF] [Request Permissions]

M. K. Bohlmann, M. von Wolff, and T. Strowitzki: Comment on the Symposium article "Fertility after treatment for Hodgkin’s disease", by Z. Blumenfeld, E. Dann, I. Avivi et al. (Ann Oncol 2002; 13 Suppl 1: 138–147)
Ann Oncol 14: 499; doi:10.1093/annonc/mdg093
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Z. Blumenfeld and E. J. Dann: Reply to Letter to the Editor on "Fertility after treatment for Hodgkin’s disease", by M. K. Bohlmann, M. von Wolff & T. Strowitzki (Ann Oncol 2003; 14: 499)
Ann Oncol 14: 499-500; doi:10.1093/annonc/mdg094
[Extract] [FREE Full Text] [PDF] [Request Permissions]

M. E. Thompson and M. S. Highley: Interaction between paclitaxel and warfarin
Ann Oncol 14: 500; doi:10.1093/annonc/mdg096
[Extract] [FREE Full Text] [PDF] [Request Permissions]

A. Trojan, E. Chasse, B. Gay, G. Pichert, and C. Taverna: Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma
Ann Oncol 14: 501-502; doi:10.1093/annonc/mdg095
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

M. Tamburini: I. Higginson, A. Carr, P. Robinson (eds). Quality of Life
Ann Oncol 14: 503; doi:10.1093/annonc/mdg115
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. J. T. Wagener: J. Lugton. Communicating with dying people and their relatives
Ann Oncol 14: 503-504; doi:10.1093/annonc/mdg116
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Online ISSN 1569-8041 - Print ISSN 0923-7534

Oxford Journals Oxford University Press